Sales: $1.85 billion
Key Personnel: Bris Rocher, chairman and chief executive officer; Yann-Eitenne Le Gall, deputy chief executive officer, human resources, communication and organization.
Major Products: Yves Rocher, Stanhome, Dr. Pierre Ricaud, Danel Jouvance, Kiotis, ID Parfums, Flormar.
New Products: Yves Rocher—Jumbo eye pencil, concentrated shower gel, bronzing powder duo, highlights shampoos; Dr. Pierre Ricaud—Hyalurides LP anti-wrinkle cream, Luminexpert radiance recovery anti-aging cream, Luminexpert anti-fatigue and dark circle correcting 3-in-1 eye treatment, Luminexpert four-week vitality treatment, Hyalurides LP anti-wrinkle resurfacing serum; Hyalurides LP filling anti-wrinkle eye cream, Hydra-Rides express plumping mask, Hydra-Rides wrinkle replumping hydration booster, Intense Eyes mascara and eyeshadow, Nourished and Plumped lip treatment, Éclat d’Hiver high repair lip butter, Sérum de Teint, Summer Skin, Ongles Parfaits intense color nail polish, Enhancing hair oil, body roller, 24Hr Hydrating body lotion, Intelligence Fermeté, High Nutrition dry body oil, Summer Skin radiance enhancer, Fleurs de Kyoto women’s fragrance and shower oil, Jardin d’Andalousie bath and shower gel, Ode á l’Amour. Acquisition—Sabon.
Comments: Privately-held Rocher Group was founded in 1959 by botanist Yves Rocher. The company is now controlled by his grandson Bris Rocher. Rocher Group proudly notes that it was the first European cosmetics company to put an end to animal testing.
Rocher operates in more than 100 countries with nearly 40% of sales coming from its home market. Western Europe accounts for about 33% of sales, followed by Eastern Europe, South America, Middle East, Asia, North America and others.
In December, Rocher paid nearly $130 million for a majority stake in Sabon, an Israeli cosmetics company. Best known for its bath and body collections, Sabon has 175 stores around the world, primarily in its home market.